Cysteamine Decreases Low-Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low-Density Lipoprotein Receptor-Deficient Mice.

J Am Heart Assoc · 2021 · PMC8649511 · PMID 34493066

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

of borderline significanceP =0.057so close (0.05 < p ≤ 0.1)

Cysteamine Reduces Lipids and Inflammation in the Liver The mean total hepatic cholesterol in the cysteamine‐treated mice was much less than in the baseline mice ( P <0.01) and the control mice (but of borderline significance when compared with the control mice, P =0.057) (Figure 5A ).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.